Portrait of Amy Gasbarro, Chief Operating Officer at Vālenz

Vālenz Appoints Amy Gasbarro as Chief Operating Officer

PHOENIX, Ariz. (February 17, 2020) — The Board of Directors at Vālenz™ has appointed Amy Gasbarro as Chief Operating Officer. Since 2018, Gasbarro has served as President of Vālenz Care, the firm’s care management solution.

“I commend the Board for their decision to appoint Amy to this role,” said Rob Gelb, the firm’s new Chief Executive Officer, adding that Gasbarro’s leadership background spans two decades at companies focused on population health and cost management solutions for self-funded employers. “Her expertise, combined with her shared vision for the future of Valenz, make her an excellent choice to oversee operations for the next high-growth phase of our company.”

In addition to her leadership role at Valenz, Gasbarro is actively involved in committees that advocate for self-insured employers, including the Government Relations Committee for the Self-Insurance Institute of America (SIIA) and the SIIA Political Action Committee. Such involvement ensures she has a seat at the table as a voice for self-funded groups, helping to steer public policy in support of favorable outcomes – namely, lower-cost, higher-quality healthcare.

Those outcomes are at the heart of everything they do at Valenz, says Gasbarro, where delivering on the company’s promise involves taking every opportunity to engage early and often for smarter, better, faster healthcare. As COO, Gasbarro is committed to supporting the Valenz team as the enterprise grows, and as its flagship platform – the industry’s first complete, end-to-end health administrative ecosystem – expands.

“Through the analytic and predictive power of the Valenz ecosystem, we are continuously broadening our ability to influence better health outcomes and reduce total cost of care,” said Gasbarro. “This is a very exciting time for Valenz, and I look forward to my new role in shaping a more prosperous future for our company, and more importantly, for our clients.”

About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. For more information, visit www.valenzhealth.com. Valenz is backed by Great Point Partners.

About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.

2020 Year of the Nurse: Vālenz Celebrates the Impact of Nursing Excellence

As the innovators behind a new, data-driven ecosystem that reduces medical claim costs and promotes quality healthcare, Vālenz™ joins the World Health Organization in recognizing 2020 as the Year of the Nurse. Integral to Valenz’s services is its team of nurse case managers, who work closely with patients, providers, employers and payers to target the most appropriate levels of care before services are rendered, resulting in substantial savings for plans and members.

“Nurse case managers are essential to the Valenz promise of engaging early and often for smarter, better, faster healthcare,” said Amy Gasbarro, President of Vālenz Care, a triple-URAC accredited solution within the firm’s complete healthcare administrative ecosystem. “Their work improves quality and outcomes while also empowering our clients to move from reactive plan models to proactive population health management.”

For patients, nurse case managers are advocates for high-quality, lower-cost care – and many registered nurses on the Valenz team specialize in common and costly health conditions such as diabetes, cancer and pregnancy, among others. For self-insured employers and other professional stakeholders, nurse case managers help manage health administrative costs and quality by reducing expensive, unnecessary and/or preventable emergency room visits, hospitalizations, tests and other high-dollar claim events.

“Driven by actionable data — both individualized and aggregated — our Case Management solution ensures comprehensive care while minimizing out-of-pocket costs,” said Rob Gelb, Chief Revenue Officer of Valenz. “Our nurses serve as a central point of contact, guiding clients through treatment, so they can focus on what matters most — returning to good health.”

For all these reasons and more, says Gelb, Valenz is proud to celebrate the incredible impact of nursing excellence – this year and every year. For more information about Valenz Care, call (877) 601-2200.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Visit Great Point at www.gppfunds.com.

Vālenz Becomes SIIA Diamond Member

PHOENIX, Ariz. (January 9, 2020) – Vālenz™ is pleased to announce that it has become a Diamond member company of the Self-Insurance Institute of America, Inc. (SIIA). Diamond membership signifies the highest level of support for SIIA and demonstrates a company’s leadership position within the self-insurance/captive insurance marketplace.

“We are proud and honored to support SIIA in its mission, and our recent decision to become a Diamond member reflects the strength of our commitment – and theirs – to serving the needs of the self-insured community,” said Valenz Chief Revenue Officer Rob Gelb. “Our involvement with SIIA over the years has been integral to our ability to develop innovative solutions that reduce medical claim costs and promote quality healthcare. Diamond member status is one of many ways we are giving back to an organization that has given so much to us, and to the self-insured community we serve daily.”

Through a complete health administrative ecosystem that connects cost and quality data on a single-source, end-to-end analytics platform, Valenz helps self-insured employers achieve smarter, better, faster healthcare at significant cost savings. By integrating data from its core services – which comprise care management, high-value provider networks, claim workflow management, payment integrity, revenue cycle management and eligibility compliance – Valenz delivers solutions that reduce total cost of care while improving health outcomes for America’s workforce.

The continued growth in the number of SIIA Diamond members reflects recognition by leading-industry companies of the importance to provide robust support to the trade association that is best positioned to protect and promote their business interests. This support has enabled SIIA to further improve and expand its membership service capabilities. Learn more at siia.org.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners. To learn more about Valenz, visit www.valenzhealth.com

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Learn more at www.gppfunds.com.

Portrait of Greg Shelley, Senior Client Services Executive at Vālenz

Greg Shelley Joins Vālenz Team as Senior Client Services Executive

PHOENIX, Ariz. (January 8, 2020) — In keeping with an ongoing commitment to expand its services and client base, leaders at Vālenz™ are pleased to announce the appointment of Greg Shelley as Senior Client Services Executive. Shelley joined the team at Vālenz – a leading innovator for solutions that connect cost and quality data on a single, end-to-end analytics platform to reduce medical claim costs and promote quality healthcare – in late December.

“Greg brings a unique mix of strengths to this role, including his skills in relationship-building, client service, strategic execution and data analysis,” said Rob Gelb, Chief Revenue Officer. “Those attributes, combined with his consultative spirit and passion for helping clients solve challenges, have positioned him well to bring new solutions to Valenz clients. We are proud to have him on board.”

“It’s an honor to join the Valenz team because the promise of ‘smarter, better, faster healthcare’ is so compelling and, more important, so in demand,” said Shelley. “More than most, the people of Valenz understand how to reduce the total cost of care and have been making the smart, strategic moves necessary to bring results-driven solutions to our clients.”

As a candidate, Shelley was drawn to the firm’s innovative approach to data science. Now, as a member of the team, he says he’s wholly inspired by it and looks forward to finding new ways to foster ongoing growth. With a degree in Business Administration from West Texas A&M University, Shelley has held a variety of management and leadership roles, most recently at One Call, a provider of healthcare solutions for the workers’​ compensation industry, where he served as vice president of business development.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. For more information, visit www.gppfunds.com.

Portrait of Tom Cox, Vice President, Client Services at Vālenz

Tom Cox, MBA, Joins Vālenz Team as Vice President of Client Services

PHOENIX, Ariz. (January 8, 2020) — To support continuous expansion of the Vālenz™ ecosystem and deliver solutions that meet the ever-evolving needs of their clients and partners, Valenz officials today announced the appointment of Tom Cox, MBA, as Vice President of Client Services. Cox joins the team in mid-January to lead the client services and business development support teams.

“Tom has a deep conviction for delivering service excellence and creating value for clients, partners and shareholders,” said Rob Gelb, Chief Revenue Officer. “His leadership experience and ability to leverage data for client solutions have positioned him well to head up our client services team.”

Cox says he has always been passionate about delivering service excellence because he believes great service is the key to strong, long-lasting relationships. In addition to overseeing client services – the first point of contact for the firm’s large and growing client base – Cox plays a key role in data-driven growth and development of existing business.

“With healthcare as complex as it is, I am really excited about the depth of Valenz analytics,” said Cox. “We have a great line of sight into client trends and needs, allowing us to pinpoint opportunities to truly bend the cost curve in healthcare.”

Having held a number of leadership positions in customer service, most recently at Philadelphia Insurance Companies and Aqua America, Cox brings extensive experience to his new role. He earned his master’s degree from Arcadia University in Pennsylvania after completing his bachelor’s degree in psychology from the State University of New York at Albany. He is also nationally certified in coaching, training and facilitation. His education, combined with more than a decade of versatile business experience, has inspired Cox to deliver creative approaches, fresh thinking and data-driven insights to service delivery.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. For more information, visit www.gppfunds.com.

Portrait of Kevin Gorham, SPHR, SHRM-SCP, Vice President of Human Resources at Vālenz

‘Best People, Best Practices’: Vālenz Elevates HR Function with Appointment of New Vice President

PHOENIX, Ariz. (January 6, 2020) — As healthcare companies grow and evolve, so too does the need for enhanced talent acquisition, employee engagement, cultural cohesion and more. Those and other HR functions are what Kevin Gorham, SPHR, SHRM-SCP, plans to address strategically in his new role as Vice President of Human Resources at Vālenz™.

“As the nation’s first fully integrated health administrative ecosystem, Valenz is charting significant growth, underscoring the need to invest in our human resources infrastructure,” said Larry Eisel, Chief Financial Officer. “Because much of our growth will continue to come from leveraging the integration of new and existing companies and partners into one synergistic ecosystem, we knew Kevin’s previous successes with corporate integration, employee engagement and cultural alignment made him the ideal fit to lead our human resources department.”

An award-winning human resources executive with 20 years’ experience leading organizations in such industries as healthcare, technology and financial services, Gorham describes his leadership style as a strategic business partnership model and says his guiding philosophy is “best people, best practices.” That approach has led to a career filled with corporate successes, from improving operations to achieving record-high employee engagement.

“For me, professional fulfillment comes from being part of a growing company, which brings many opportunities to evolve through innovative and forward-thinking practices,” explained Gorham. “I am honored to join the Valenz team and look forward to contributing to our ongoing success through excellence in human resources management and team support.”

Gorham has both a master’s and bachelor’s degree in English from Eastern Illinois University, where he learned the art and science of effective communication. Later, while at Household International (now part of HSBC Corporation), he received the company’s Award for Excellence for his work in human resources and employee communications. In his HR leadership role at Avnet, he was one of three finalists for the President’s Award for his work in talent management. Gorham is a Senior Certified Professional in Human Resources and an active member of the Society for Human Resources Management.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Visit Great Point at www.gppfunds.com.

Image of people using integrated systems on their computers

Vālenz Embeds Spiro into Ecosystem for Added Insights into Customer Needs

PHOENIX, Ariz. (December 19, 2019) — With a laser focus on changing the trajectory of total healthcare spending, which surpassed $3.6 trillion in 2018 and is expected to rise 5.5% to exceed $3.8 trillion in 2019, Vālenz™ announced the integration of Spiro into its health administrative ecosystem. As a proactive relationship management solution typically used to boost efficiency and effectiveness, Spiro provides Valenz teams with a transparent lens into new and existing client activity. The resulting insights quickly illuminate new ways to disrupt the cost curve for Valenz clients, which include self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers.

“By embedding Spiro into our business processes, we can extract meaningful data from client interactions, giving everyone across our enterprise actionable business intelligence to help our clients reduce their total cost of care,” said Rob Gelb, Chief Revenue Officer at Valenz. Spiro’s AI platform offers tremendous efficiencies for the Valenz team and, as Gelb explains, “It’s a game-changer for our clients because now we can consolidate their information across text messages, calls and documents to rapidly deploy new solutions for our clients.”

According to Adam Honig, CEO and co-founder of Spiro, companies that use Spiro’s AI-driven, proactive relationship management platform can expect to work smarter and close faster – and for innovative firms like Valenz, there are opportunities to take things to the next level. “I’m impressed at how Valenz is integrating our platform into its ecosystem to generate value well beyond their own benefit,” Honig said. “They are clearly a forward-thinking firm, using our platform to engage early and often to reduce the cost of healthcare for their clients.”

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.

About Spiro.AI

Spiro is the first proactive relationship management platform. Natively built on artificial intelligence, Spiro provides a single solution encompassing traditional CRM, sales enablement and telephony. Spiro’s AI engine eliminates the need for data entry and proactively guides salespeople to the right actions at the right time. Customers report collecting 8 times more data, reaching 47% more prospects and closing 20% more deals after using Spiro. For more information, visit www.spiro.ai.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Visit Great Point at www.gppfunds.com.

Larry Eisel, CPA, CMA, CGMA, Chief Financial Officer

Vālenz Appoints Larry Eisel as Chief Financial Officer

PHOENIX, Ariz. (December 16, 2019) — Today, leaders at Vālenz™ announced the appointment of Larry Eisel, CPA, CMA, CGMA, as Chief Financial Officer. In addition to overseeing all financial operations, Eisel will play a key role in strategic planning and establishing sustainable growth goals for Valenz.

Eisel’s background in finance spans more than three decades, including 11 years as CFO for Total Transit, which included Veyo, a healthcare logistics data analytics firm. As such, Eisel brings the right mix of industry experience, financial acumen and leadership strength to the Valenz executive team.

“At Valenz, our promise of smarter, better, faster healthcare requires some of the smartest minds in business, and Larry has the vision and experience we need to lead our enterprise to new heights,” said Rob Gelb, Chief Revenue Officer. “With his prior success in building and managing the finances of growth-oriented companies, I am certain Larry will deliver the results we need to continuously expand our capabilities.”

As a testament to Eisel’s expertise, which includes leadership in mergers and acquisitions, divestitures, risk management, contract management, accounting, compliance, purchasing and more, he was named 2014 CFO of the Year by Financial Executives International. He also received the Outstanding CFO award from the Phoenix Business Journal the same year. Eisel says he is drawn to innovative companies that make a measurable impact by consolidating once-disparate service offerings under one roof, which led him to Valenz and its complete health administrative ecosystem.

“Valenz is extremely well positioned to transform claim management through data science and first-of-its-kind integration, and I am excited to join a team so heavily focused on bringing real savings and solutions to its customers,” Eisel said. “I look forward to the future and doing my part to continually expand the true potential of Valenz.”

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at (203) 971-3300 or www.gppfunds.com.

Portrait of Ben Inabinet, Senior Sales Executive, Vālenz

Vālenz Welcomes Ben Inabinet as Senior Sales Executive

Vālenz™, a leading innovator for solutions that reduce medical claim costs and promote quality healthcare, recently welcomed Ben Inabinet to the team as Senior Sales Executive. As an experienced sales professional and account executive, Inabinet has a proven track record of delivering efficiency and cost savings through IT solutions for third-party administrators, insurance carriers, self-insured employers and other clients.

Prior to joining Valenz, Inabinet worked as a Channel Manager for NetClaim. His work experience also includes sales and account positions at such firms as Team IA and ScanSource. Today, he says he is thrilled to bring his career to the next level through Valenz and the industry’s first complete health administrative ecosystem.

“As healthcare spending continues to rise, today’s health administrators need new approaches that drive lower costs and better outcomes,” Inabinet said. “Valenz helps clients achieve smarter, better, faster healthcare through highly integrated, data-driven solutions, so I am truly honored to join such a client-centric and future-focused team.”

Rob Gelb, Chief Revenue Officer, says Inabinet brings the right mix of industry knowledge, problem-solving skills and innovative spirit to the Valenz sales team, which is integral to serving the needs of Valenz’s customer base. “The more we grow, the more robust our analytic and predictive capabilities become, making our ecosystem grow in value for our clients every day,” Gelb explained.

For more information, call 866-762-4455.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners. For more information about Valenz, visit www.valenzhealth.com or call (866) 762-4455.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm, currently with approximately $1.8 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at (203) 971-3300 or www.gppfunds.com.

Colin Glen Joins Senior Executive Team at Vālenz Assurance

Vālenz, a leading innovator for solutions that reduce medical claim costs and promote quality healthcare, has recently expanded its strategic acumen by welcoming Colin Glen to the executive team. Glen is now Vice President of Business for Vālenz Assurance, which delivers solutions for assured compliance and payment integrity as part of the firm’s comprehensive health administrative ecosystem.

Having held leadership positions at such firms as Intelligent Medical Solutions, Oration, WhiteCloud Analytics and, most recently, Relias, Glen brings nearly 20 years’ experience to his new role.

“Throughout his career, Colin has excelled at serving the needs of the health industry with technology and data-driven solutions,” said Rob Gelb, Chief Revenue Officer at Valenz. “He has an in-depth understanding of our clients’ needs and how to address them with our innovative and uniquely comprehensive platform. We are thrilled to have him on the Valenz team.”

Glen is well-positioned to support the Valenz growth strategy – and that growth, he says, is a key component to smarter, better, faster healthcare. “We ensure the integrity of data for clients who rely on our coding, compliance and credentialing solutions, as well as for the Valenz ecosystem,” Glen explained. “Ultimately, our solutions positively affect our clients’ capacity to reduce costs while improving care quality and outcomes.”

For more information about the complete health administrative ecosystem or any of its core components available through Valenz, call 877-762-4455.

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners. For more information about Valenz, visit www.valenzhealth.com or call (866) 762-4455.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm, currently with approximately $1.8 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at (203) 971-3300 or www.gppfunds.com.